Treprostinil treatment decreases circulating platelet microvesicles and their procoagulant activity in pediatric pulmonary hypertension

NC Bacha, M Levy, CL Guerin… - Pediatric …, 2019 - Wiley Online Library
Background Pulmonary arterial hypertension (PAH) results from pulmonary vascular
disease and may eventually lead to right heart failure and death. Vasodilator therapy has …
被引用次数：17 相关文章

Treprostinil treatment decreases circulating platelet microvesicles and their procoagulant activity in pediatric pulmonary hypertension.

NC Bacha, M Levy, CL Guerin, B Le Bonniec… - Pediatric …, 2018 - europepmc.org
Background Pulmonary arterial hypertension (PAH) results from pulmonary vascular
disease and may eventually lead to right heart failure and death. Vasodilator therapy has …

Treprostinil treatment decreases circulating platelet microvesicles and their procoagulant activity in pediatric pulmonary hypertension

NC Bacha, M Levy, CL Guerin… - Pediatric …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Pulmonary arterial hypertension (PAH) results from pulmonary vascular
disease and may eventually lead to right heart failure and death. Vasodilator therapy has …